Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
R129533-1g | 1g | In stock | $205.90 | |
R129533-5g | 5g | In stock | $927.90 | |
R129533-25g | 25g | In stock | $4,171.90 | |
R129533-100g | 100g | In stock | $15,017.90 |
Synonyms | riluzole|1744-22-5|Rilutek|2-Amino-6-(trifluoromethoxy)benzothiazole|6-(trifluoromethoxy)benzo[d]thiazol-2-amine|6-(trifluoromethoxy)-1,3-benzothiazol-2-amine|RP-54274|Riluzolum|Riluzol|2-amino-6-trifluoromethoxybenzothiazole|2-Benzothiazolamine, 6-(trifl |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | Glutamate release inhibitor; anticonvulsant |
Shipped In | Normal |
Grade | Moligand™ |
Action Type | ACTIVATOR, BLOCKER, CHANNEL BLOCKER, GATING INHIBITOR |
Mechanism of action | Sodium channel alpha subunit blocker |
Product Description | Riluzole is a drug used to treat amyotrophic lateral sclerosis. |
ALogP | 3.6 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488179874 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488179874 |
IUPAC Name | 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine |
INCHI | InChI=1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13) |
InChi Key | FTALBRSUTCGOEG-UHFFFAOYSA-N |
Canonical SMILES | C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N |
Isomeric SMILES | C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N |
WGK Germany | 3 |
RTECS | DL2830000 |
PubChem CID | 5070 |
Molecular Weight | 234.2 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
J22111427 | Certificate of Analysis | Jul 10, 2024 | R129533 |
J22111435 | Certificate of Analysis | Jul 10, 2024 | R129533 |
J22111436 | Certificate of Analysis | Jul 10, 2024 | R129533 |
J2212054 | Certificate of Analysis | Jul 10, 2024 | R129533 |
F1502089 | Certificate of Analysis | Jan 25, 2023 | R129533 |
C2116156 | Certificate of Analysis | Jan 11, 2023 | R129533 |
C2116157 | Certificate of Analysis | Jan 11, 2023 | R129533 |
C2116158 | Certificate of Analysis | Jan 11, 2023 | R129533 |
D23261188 | Certificate of Analysis | Aug 25, 2022 | R129533 |
H2212229 | Certificate of Analysis | Aug 25, 2022 | R129533 |
Solubility | DMSO 47 mg/mL Water Ethanol 47 mg/mL |
---|---|
Melt Point(°C) | 118 °C |
Pictogram(s) | GHS06 |
---|---|
Signal | Danger |
Hazard Statements | H301:Toxic if swallowed |
Precautionary Statements | P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P330:Rinse mouth. P301+P316:IF SWALLOWED: Get emergency medical help immediately. |
WGK Germany | 3 |
RTECS | DL2830000 |
Merck Index | 8223 |
Starting at $1,046.90
Starting at $813.90
Starting at $46.90
Starting at $29.90
1. Mostert JP, Koch MW, Heerings M, Heersema DJ, De Keyser J. (2008) Therapeutic potential of fluoxetine in neurological disorders.. CNS Neurosci Ther, 14 (2): (153-64). [PMID:18482027] |
2. Killestein J, Kalkers NF, Polman CH. (2005) Glutamate inhibition in MS: the neuroprotective properties of riluzole.. J Neurol Sci, 233 (1-2): (113-5). [PMID:15949499] |
3. Arun T, Tomassini V, Sbardella E, de Ruiter MB, Matthews L, Leite MI, Gelineau-Morel R, Cavey A, Vergo S, Craner M et al.. (2013) Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.. Brain, 136 (Pt 1): (106-15). [PMID:23365093] |
4. Mostert J, Heersema T, Mahajan M, Van Der Grond J, Van Buchem MA, De Keyser J. (2013) The effect of fluoxetine on progression in progressive multiple sclerosis: a double-blind, randomized, placebo-controlled trial.. ISRN Neurol, 2013 (3): (370943). [PMID:23984093] |
5. Huang CS, Song JH, Nagata K, Yeh JZ, Narahashi T. (1997) Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons.. J Pharmacol Exp Ther, 282 (3): (1280-90). [PMID:9316836] |